Antipsychotic medications can help a person with bipolar disorder stabilize their moods, reduce agitation, and improve overall quality of life. Learn more about the medication types, dosage, side ...

Beloved TV star Madchen Amick has been talking about navigating her son Sly’s Bipolar 1 diagnosis together, and how in 2025, ...

He caught it really fast, and they changed that medication immediately and ... and downs in mood and energy,” often called “manic-depressive disorder” or “manic depression.” ...

Some have already tried numerous medications ... treating the mood disorder first until the patient is “stabilized.” Stabilized is the key word here, particularly if the patient is suicidal, manic, or ...

Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.

If approved, CAPLYTA ® has the potential to be the first treatment approved for MDD and depressive symptoms associated with bipolar I and II in more than 15 years. Additional Phase 3 trials are ...

Award-winning author, Professor Paul Crawford tells us about how his latest novel, The Wonders of Doctor Bent, drew on the ...

Friday morning and afternoon, officials conducted a deliberate — and sometimes difficult — serious mental illness hearing for ...

A Cleveland Clinic psychiatrist discusses what the latest research suggests causes bipolar, what the individual experiences, ...

JNJ-18038683 is under clinical development by Johnson & Johnson and currently in Phase II for Bipolar Disorder (Manic Depression). According to GlobalData, Phase II drugs for Bipolar Disorder (Manic ...

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...